Company intelligence / Profile preview

Zhejiang Haixin Zhihui Technology Co., Ltd.

Hangzhou, Zhejiang, Chinapreqin.com ↗

Ownership: Private
Development stage: Other

Overview

The company has developed and commercialized an AI-powered intelligent diagnosis and treatment system, including the "Haixin anti-cancer app," which provides precise recommendations and full disease management for cancer patients. It also develops digital therapeutics and supports clinical new drug development. No specific published clinical trial results are available in public sources.

Therapeutic areas: Oncology
Modalities: Digital therapeuticsArtificial intelligence-based therapy support systemsSmall molecule (clinical new drugs)
Industry: Digital Health Medical Devices

Partnerships

Not specifically listed in public sources.

Beyond the preview

Go deeper on Zhejiang Haixin Zhihui Technology Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Haixin Zhihui Technology Co., Ltd..

Explore the full profile